M. Leimer

1.1k total citations
26 papers, 871 citations indexed

About

M. Leimer is a scholar working on Epidemiology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, M. Leimer has authored 26 papers receiving a total of 871 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 13 papers in Oncology and 10 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in M. Leimer's work include Neuroendocrine Tumor Research Advances (18 papers), Radiopharmaceutical Chemistry and Applications (10 papers) and Lung Cancer Research Studies (10 papers). M. Leimer is often cited by papers focused on Neuroendocrine Tumor Research Advances (18 papers), Radiopharmaceutical Chemistry and Applications (10 papers) and Lung Cancer Research Studies (10 papers). M. Leimer collaborates with scholars based in Austria, United Kingdom and Japan. M. Leimer's co-authors include Irene Virgolini, P. Angelberger, Amir Kurtaran, Markus Raderer, Bruno Niederle, Shuren Li, Peter Valent, Werner Scheithauer, Thomas Pangerl and Klaus Kaserer and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

M. Leimer

26 papers receiving 849 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Leimer Austria 18 522 426 311 261 99 26 871
Markus Raderer Austria 18 610 1.2× 576 1.4× 313 1.0× 264 1.0× 148 1.5× 30 1.0k
Shaobo Yao China 19 325 0.6× 692 1.6× 311 1.0× 138 0.5× 199 2.0× 60 1.2k
M. van Hagen Netherlands 3 1.0k 2.0× 739 1.7× 374 1.2× 666 2.6× 80 0.8× 5 1.4k
Chiara Grana Italy 7 283 0.5× 318 0.7× 281 0.9× 206 0.8× 87 0.9× 8 696
A. Srinivasan United States 13 631 1.2× 610 1.4× 608 2.0× 309 1.2× 122 1.2× 20 1.1k
Christopher McPherson United States 20 292 0.6× 199 0.5× 78 0.3× 257 1.0× 319 3.2× 33 1.2k
Jan‐Erik Westlin Sweden 14 283 0.5× 449 1.1× 524 1.7× 278 1.1× 134 1.4× 36 1.1k
Ulrike Garske‐Román Sweden 13 663 1.3× 679 1.6× 749 2.4× 416 1.6× 86 0.9× 19 1.3k
Alberta Aikin United States 14 78 0.1× 187 0.4× 123 0.4× 130 0.5× 141 1.4× 16 650
Emmanuel Gautherot France 20 85 0.2× 290 0.7× 887 2.9× 68 0.3× 227 2.3× 34 1.2k

Countries citing papers authored by M. Leimer

Since Specialization
Citations

This map shows the geographic impact of M. Leimer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Leimer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Leimer more than expected).

Fields of papers citing papers by M. Leimer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Leimer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Leimer. The network helps show where M. Leimer may publish in the future.

Co-authorship network of co-authors of M. Leimer

This figure shows the co-authorship network connecting the top 25 collaborators of M. Leimer. A scholar is included among the top collaborators of M. Leimer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Leimer. M. Leimer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gruber, Reinhard, M. Leimer, Michael B. Fischer, & Hermann Agis. (2013). Beta2-adrenergic receptor agonists reduce proliferation but not protein synthesis of periodontal fibroblasts stimulated with platelet-derived growth factor-BB. Archives of Oral Biology. 58(12). 1812–1817. 6 indexed citations
2.
Traub‐Weidinger, Tatjana, Markus Raderer, Martin Uffmann, et al.. (2011). Improved Quality of Life in Patients Treated with Peptide Radionuclides. SHILAP Revista de lepidopterología. 10(2). 115–121. 10 indexed citations
3.
Rodrigues, Margarida, Tatjana Traub‐Weidinger, M. Leimer, et al.. (2005). Value of 111In-DOTA-lanreotide and 111In-DOTA-DPhe1-Tyr3-octreotide in differentiated thyroid cancer: results of in vitro binding studies and in vivo comparison with 18F-FDG PET. European Journal of Nuclear Medicine and Molecular Imaging. 32(10). 1144–1151. 19 indexed citations
4.
Virgolini, Irene, M. Leimer, Shuren Li, et al.. (2002). Experience with Indium-111 and Yttrium-90-Labeled Somatostatin Analogs. Current Pharmaceutical Design. 8(20). 1781–1807. 74 indexed citations
5.
6.
Virgolini, Irene, M. Leimer, Shuren Li, et al.. (2001). New trends in peptide receptor radioligands.. PubMed. 45(2). 153–9. 37 indexed citations
7.
Virgolini, Irene, M. Leimer, Thomas Pangerl, et al.. (2000). New radiopharmaceuticals for receptor scintigraphy and radionuclide therapy.. PubMed. 44(1). 50–8. 18 indexed citations
8.
Smith‐Jones, Peter, Claudia Bischof, M. Leimer, et al.. (1999). DOTA-Lanreotide: A Novel Somatostatin Analog for Tumor Diagnosis and Therapy1. Endocrinology. 140(11). 5136–5148. 69 indexed citations
9.
Raderer, Markus, Julia Valencak, Werner Scheithauer, et al.. (1998). Expression of Human Somatostatin Receptor Subtype 3 in Pancreatic Cancer In Vitro and In Vivo. JNCI Journal of the National Cancer Institute. 90(21). 1666–1668. 10 indexed citations
10.
Virgolini, Irene, Amir Kurtaran, P. Angelberger, et al.. (1998). Indium-111-DOTA-lanreotide: biodistribution, safety and radiation absorbed dose in tumor patients.. PubMed. 39(11). 1928–36. 67 indexed citations
11.
Virgolini, Irene, M. Leimer, Klaus Kaserer, et al.. (1998). Location of a VIPoma by iodine-123-vasoactive intestinal peptide scintigraphy.. PubMed. 39(9). 1575–9. 18 indexed citations
12.
Leimer, M., Amir Kurtaran, Peter Smith‐Jones, et al.. (1998). Response to treatment with yttrium 90-DOTA-lanreotide of a patient with metastatic gastrinoma.. PubMed. 39(12). 2090–4. 46 indexed citations
13.
Peck‐Radosavljevic, Markus, M. Leimer, Claudia Bischof, et al.. (1998). The somatostatin receptor (SSTR) subtype 3 ACTS as an acceptor of vasocative intestinal peptide (VIP). Gastroenterology. 114. A1172–A1172. 3 indexed citations
14.
Geißler, Klaus, Leopold Öhler, Manuela Födinger, et al.. (1996). Interleukin 10 inhibits growth and granulocyte/macrophage colony-stimulating factor production in chronic myelomonocytic leukemia cells.. The Journal of Experimental Medicine. 184(4). 1377–1384. 49 indexed citations
15.
Virgolini, Irene, P. Angelberger, Shuren Li, et al.. (1996). In vitro and in vivo studies of three radiolabelled somatostatin analogues:123I-Octreotide (OCT),123I-Tyr-3-OCT and111In-TIRA-d-Phe-1-OCT. European Journal of Nuclear Medicine and Molecular Imaging. 23(10). 1388–1399. 30 indexed citations
16.
Virgolini, Irene, Markus Raderer, Amir Kurtaran, et al.. (1996). 123I-vasoactive intestinal peptide (VIP) receptor scanning: Update of imaging results in patients with adenocarcinomas and endocrine tumors of the gastrointestinal tract. Nuclear Medicine and Biology. 23(6). 685–692. 39 indexed citations
17.
Leimer, M., Klaus Kaserer, Qiong Yang, et al.. (1996). Combined use of 111in-DTPA-D-Phe-1-octreotide (OCT) and 123I-vasoactive intestinal peptide (VIP) in the localization diagnosis of medullary thyroid carcinoma (MTC). Nuclear Medicine and Biology. 23(4). 503–507. 10 indexed citations
18.
Raderer, Markus, Alexander Becherer, P. Angelberger, et al.. (1996). Comparison of iodine-123-vasoactive intestinal peptide receptor scintigraphy and indium-111-CYT-103 immunoscintigraphy.. PubMed. 37(9). 1480–7. 9 indexed citations
19.
Kurtaran, Amir, Shuren Li, Markus Raderer, et al.. (1995). Technetium-99m-galactosyl-neoglycoalbumin combined with iodine-123-Tyr-(A14)-insulin visualizes human hepatocellular carcinomas.. PubMed. 36(10). 1875–81. 17 indexed citations
20.
Virgolini, Irene, Amir Kurtaran, Markus Raderer, et al.. (1995). Vasoactive intestinal peptide receptor scintigraphy.. PubMed. 36(10). 1732–9. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Markus Raderer Breakdown of academic impact, for papers by Shaobo Yao Breakdown of academic impact, for papers by M. van Hagen Breakdown of academic impact, for papers by Chiara Grana Breakdown of academic impact, for papers by A. Srinivasan Breakdown of academic impact, for papers by Christopher McPherson Breakdown of academic impact, for papers by Jan‐Erik Westlin Breakdown of academic impact, for papers by Ulrike Garske‐Román Breakdown of academic impact, for papers by Alberta Aikin Breakdown of academic impact, for papers by Emmanuel Gautherot
Rankless by CCL
2026